Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
Author(s) -
Joshua Stripling,
Ranjit Kumar,
John W. Baddley,
Anoma Nellore,
Paula Dixon,
Donna Howard,
Travis Ptacek,
Elliot J. Lefkowitz,
José Tallaj,
William H. Benjamin,
Casey D. Morrow,
J. Martín Rodríguez
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv078
Subject(s) - clostridium difficile , medicine , clostridium difficile colitis , fecal bacteriotherapy , vancomycin resistant enterococcus , feces , enterococcus , vancomycin , colitis , diarrhea , microbiology and biotechnology , antibiotics , biology , bacteria , staphylococcus aureus , genetics
We report the use of fecal microbiota transplantation in a single heart-kidney transplant recipient with recurrent Clostridium difficile, vancomycin-resistant Enterococcus (VRE) fecal dominance, and recurrent VRE infections. Fecal microbiota transplantation resulted in the reconstruction of a diverse microbiota with (1) reduced relative abundance of C difficile and VRE and (2) positive clinical outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom